• Radiologic Technology News

Radiation Effective for Testicular Cancer

May 05, 2016

A new study presented at a gathering of the European Society for Therapeutic Radiology and Oncology finds that radiation is more effective than chemotherapy for one kind of testicular cancer. Researchers found that 99% of patients with stage IIA testicular seminoma disease were alive after five years if they had been treated with radiation therapy.

According to the study, the findings are counter to a prevailing tendency to move away from radiation therapy toward chemotherapy for treating stage IIA patients. Published in the journal Clinical Oncology, the analysis supports a recommendation that radiation therapy should be the preferred option for treating patients in stage IIA of the disease.

Professor Philip Poortmans, president of ESTRO, who was not involved in the research, said in a news release, “The movement away from radiation therapy in favor of chemotherapy, induced by the fear of a higher rate of late toxicity, is now suggested to be probably not the right one for patients with stage IIA testicular seminoma.”

The study analyzed data from 2,437 patients with stage IIA testicular seminoma diagnosed between 1998 and 2012 who were treated with radiation therapy or multi-agent chemotherapy after removal of the cancerous testicle. Testicular seminoma is one of the most treatable cancers if discovered early.

To comment on this article, please log in above with your ASRT member account. See commenting guidelines.

Leave a comment

    Leave a comment

      Your comments:
      Subject to approval
    1. Comment cannot be empty